Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference
Sensei Biotherapeutics, Inc. (SNSE)
Company Research
Source: GlobeNewswire
BOSTON, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that preclinical data on SNS-103 will be presented in a poster session at the CRI-ENCI Eighth International Immunotherapy Conference, being held September 8-11, 2024, at the Gaylord National Resort & Convention Center in National Harbor, MD. Presentation Details: CRI-ENCI Eighth International Cancer Immunotherapy Conference Title: Pre-clinical characterization of monoclonal antibodies targeting CD39 activity in the acidic tumor microenvironmentPresenter: F. Donelson Smith, Ph.D., Senior Director, Biologics Discovery & Early DevelopmentPoster Number: 195ADate and time: Sunday, September 8, 2024, 12:05 – 2:05 p.m. EDT About Sensei Biotherapeutics? Sensei Biotherapeutics (Nasdaq: SNSE) is a clinical stage immuno-oncology company focused on the dis
Show less
Read more
Impact Snapshot
Event Time:
SNSE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNSE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNSE alerts
High impacting Sensei Biotherapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SNSE
News
- Sensei Biotherapeutics to Present at Upcoming ConferencesGlobeNewswire
- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.MarketBeat
- Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business HighlightsGlobeNewswire
- VISTA Inhibitor Clinical Trials Drug Approval Insight [Yahoo! Finance]Yahoo! Finance
SNSE
Earnings
- 8/6/24 - Miss
SNSE
Analyst Actions
- 8/7/24 - HC Wainwright
SNSE
Sec Filings
- 9/20/24 - Form 8-K
- 8/6/24 - Form 10-Q
- 8/6/24 - Form 8-K
- SNSE's page on the SEC website